SwePub - search: WFRF:(Bertolotto Michele)

Enumeration	Reference	Cover	Find
1.	Thomsen, Henrik S., et al. (author) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines 2013 In: European Radiology. - : Springer Science and Business Media LLC. - 0938-7994 .- 1432-1084. ; 23:2, s. 307-318 Journal article (peer-reviewed)abstract To update the guidelines of the Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and gadolinium-based contrast media. Topics reviewed include the history, clinical features and prevalence of nephrogenic systemic fibrosis and the current understanding of its pathophysiology. The risk factors for NSF are discussed and prophylactic measures are recommended. The stability of the different gadolinium-based contrast media and the potential long-term effects of gadolinium in the body have also been reviewed. aEuro cent Clinical features, risk factors and prevention of nephrogenic systemic fibrosis are reviewed aEuro cent Patients with GFR below 30 ml/min/1.73 m (2) have increased risk of developing NSF aEuro cent Low stability gadolinium contrast media show the strongest association with NSF aEuro cent Following guidelines regarding gadolinium contrast agents minimises the risk of NSF aEuro cent Potential long-term harm from gadolinium accumulation in the body is discussed.

Thomsen, Henrik S., et al. (author)
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
2013
In: European Radiology. - : Springer Science and Business Media LLC. - 0938-7994 .- 1432-1084. ; 23:2, s. 307-318
Journal article (peer-reviewed)abstract
- To update the guidelines of the Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and gadolinium-based contrast media. Topics reviewed include the history, clinical features and prevalence of nephrogenic systemic fibrosis and the current understanding of its pathophysiology. The risk factors for NSF are discussed and prophylactic measures are recommended. The stability of the different gadolinium-based contrast media and the potential long-term effects of gadolinium in the body have also been reviewed. aEuro cent Clinical features, risk factors and prevention of nephrogenic systemic fibrosis are reviewed aEuro cent Patients with GFR below 30 ml/min/1.73 m (2) have increased risk of developing NSF aEuro cent Low stability gadolinium contrast media show the strongest association with NSF aEuro cent Following guidelines regarding gadolinium contrast agents minimises the risk of NSF aEuro cent Potential long-term harm from gadolinium accumulation in the body is discussed.

Träfflista för sökning "WFRF:(Bertolotto Michele) "